Sign inGet started

HOLLIMAN JOHN M III

Insider CIK 938112 · CAPS Executive Chairman, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CAPS Capstone Holding Corp. A Award2026-08-072026-08-11305,248— $0401,343SEC↗
CAPS Capstone Holding Corp. A Award2026-08-072026-08-11305,248— —401,343SEC↗
CAPS Capstone Holding Corp. A Award2026-03-302026-08-1195,000— $095,000SEC↗
CAPS Capstone Holding Corp. A Award2026-03-302026-08-1195,000— —95,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2016-01-222016-01-2550,000— $01,308,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2015-12-182015-12-21100,000— $01,268,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2015-06-192015-06-23200,000— $01,168,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2015-06-192015-06-2350,000— $0968,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2015-04-102015-04-1350,000— $0918,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2015-01-022015-01-0550,000— $0868,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2014-02-062014-02-1322,000— $0828,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2014-01-012014-01-0210,000— $0836,000SEC↗
CAPS Capstone Therapeutics Corp P Buy2013-12-062013-12-0625,000$0.26 $6.5K507,614SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2013-02-282013-03-0151,000— $0836,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2013-01-012013-01-0210,000— $0785,000SEC↗
CAPS Capstone Therapeutics Corp P Buy2012-10-192012-10-1950,000$0.14 $7.0K482,614SEC↗
CAPS Capstone Therapeutics Corp P Buy2012-10-182012-10-19100,000$0.14 $14.0K432,614SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2012-08-092012-08-1065,000— $0785,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2012-05-182012-05-2165,000— $0720,000SEC↗
CAPS Capstone Therapeutics Corp A Award deriv2012-01-012012-01-0310,000— $0715,000SEC↗
CAPS Capstone Therapeutics Corp A Award2012-01-012012-01-0310,000— $0332,614SEC↗